NOW APPROVED A NEW TREATMENT FOR PLATINUM-RESISTANT OVARIAN
CANCER IS HERE
ELAHERE is a prescription medicine used to treat adults with folate
receptor–alpha positive ovarian cancer, fallopian tube
cancer, or primary peritoneal cancer who:
have not responded to or are no longer responding to treatment with
platinum-based chemotherapy and
have received 1 to 3 prior types of chemotherapy
Your healthcare provider will perform a test to make sure that ELAHERE is
right for you.
ELAHERE was FDA-approved based on a clinical study that measured how many
patients had a tumor response and how long that response lasted. Continued
approval is dependent on the results of an ongoing study to confirm the
benefit of ELAHERE.
ELAHERE is a prescription medicine used to treat adults with folate
receptor–alpha positive ovarian cancer, fallopian tube
cancer, or primary peritoneal cancer who:
have not responded to or are no longer responding to treatment with
platinum-based chemotherapy and
have received 1 to 3 prior types of chemotherapy
Your healthcare provider will perform a test to make sure that ELAHERE is
right for you.
ELAHERE was FDA-approved based on a clinical study that measured how many
patients had a tumor response and how long that response lasted. Continued
approval is dependent on the results of an ongoing study to confirm the
benefit of ELAHERE.